Fim3-mediated autoagglutination of Bordetella pertussis
Project/Area Number |
15K19101
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Bacteriology (including mycology)
|
Research Institution | National Institute of Infectious Diseases |
Principal Investigator |
Otsuka Nao 国立感染症研究所, 細菌第二部, 主任研究官 (90596610)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 百日咳菌 / 自己凝集 / 線毛 |
Outline of Final Research Achievements |
Bordetella pertussis is the etiologic agent of whooping cough. It was known that some B. pertussis isolates cause auto-agglutination (Agg) in vitro, however the cause of Agg has not been elucidated. In this study, whole genome sequencing and immunoblot analysis of Agg and non-Agg isolates revealed that highly production of type 3 fimbriae (Fim3) is the main cause of Agg. On the other hand, Agg isolate (Fim3 high production) showed significantly higher ability of lung adhesion than non-Agg strains (fim3-deficient or Fim3 low production strains) in mouse adherence assay, indicating that highly Fim3 production has benefit for in vivo adherence.
|
Report
(4 results)
Research Products
(5 results)
-
-
[Journal Article] A Novel IgM-capture enzyme-linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis of Bordetella pertussis infection2016
Author(s)
Otsuka N, Gotoh K, Nishimura N, Ozaki T, Nakamura Y, Haga K, Yamazaki M, Gondaira F, Okada K, Miyaji Y, Toyoizumi-Ajisaka H, Shibayama K, Arakawa Y, Kamachi K.
-
Journal Title
Microbiol Immunol.
Volume: 60
Issue: 5
Pages: 326-333
DOI
Related Report
Peer Reviewed
-
-
-